Literature DB >> 20049412

Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence.

Shawna F Graves1, Scott D Kobayashi, Frank R DeLeo.   

Abstract

Staphylococcus aureus is a significant cause of human infections globally. Methicillin-resistant S. aureus (MRSA) emerged in the early 1960s and is now endemic in most healthcare facilities. Although healthcare-associated MRSA infections remain a major problem in most industrialized countries, those caused by community-associated MRSA (CA-MRSA) are now the most abundant cause of bacterial infections in the community in some parts of the world, such as the United States. The basis for the emergence and subsequent success of CA-MRSA is incompletely defined. However, the ability of the pathogen to cause disease in otherwise healthy individuals is likely attributed, in part, to its ability to circumvent killing by the innate immune system, which includes survival after phagocytosis by neutrophils. In this review, we discuss the role of neutrophils in host defense against S. aureus and highlight progress made toward understanding mechanisms of CA-MRSA virulence and pathogenesis.

Entities:  

Mesh:

Year:  2010        PMID: 20049412      PMCID: PMC2852573          DOI: 10.1007/s00109-009-0573-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  53 in total

1.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

2.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

4.  Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia.

Authors:  E E Udo; J W Pearman; W B Grubb
Journal:  J Hosp Infect       Date:  1993-10       Impact factor: 3.926

5.  Survival of Staphylococcus aureus inside neutrophils contributes to infection.

Authors:  H D Gresham; J H Lowrance; T E Caver; B S Wilson; A L Cheung; F P Lindberg
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

8.  Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin.

Authors:  Isamu Hongo; Tadashi Baba; Kanenari Oishi; Yuh Morimoto; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

9.  The survival of staphylococci within human leukocytes.

Authors:  D E ROGERS; R TOMPSETT
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

10.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  38 in total

1.  TCA cycle inactivation in Staphylococcus aureus alters nitric oxide production in RAW 264.7 cells.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Donald J Gardner; James M Musser; David Steffen; Greg A Somerville; Jay Reddy
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

2.  Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

Authors:  Chahnaz Kebaier; Robin R Chamberland; Irving C Allen; Xi Gao; Peter M Broglie; Joshua D Hall; Corey Jania; Claire M Doerschuk; Stephen L Tilley; Joseph A Duncan
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

Review 3.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

4.  Staphylococcus aureus sortase A contributes to the Trojan horse mechanism of immune defense evasion with its intrinsic resistance to Cys184 oxidation.

Authors:  Jeffrey A Melvin; Christine F Murphy; Laura G Dubois; J Will Thompson; M Arthur Moseley; Dewey G McCafferty
Journal:  Biochemistry       Date:  2011-08-10       Impact factor: 3.162

5.  High prevalence of ST121 in community-associated methicillin-susceptible Staphylococcus aureus lineages responsible for skin and soft tissue infections in Portuguese children.

Authors:  T Conceição; M Aires-de-Sousa; N Pona; M J Brito; C Barradas; R Coelho; T Sardinha; L Sancho; G de Sousa; M do Céu Machado; H de Lencastre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-03       Impact factor: 3.267

6.  Accentuate the (Gram) positive.

Authors:  Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2010-02-20       Impact factor: 4.599

Review 7.  Modulation of connexin signaling by bacterial pathogens and their toxins.

Authors:  Liesbeth Ceelen; Freddy Haesebrouck; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Cell Mol Life Sci       Date:  2011-06-09       Impact factor: 9.261

8.  Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species.

Authors:  Huamei Forsman; Karin Christenson; Johan Bylund; Claes Dahlgren
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

9.  Characterization of Staphylococcus aureus cardiolipin synthases 1 and 2 and their contribution to accumulation of cardiolipin in stationary phase and within phagocytes.

Authors:  T Koprivnjak; D Zhang; C M Ernst; A Peschel; W M Nauseef; J P Weiss
Journal:  J Bacteriol       Date:  2011-06-10       Impact factor: 3.490

10.  Genetic tools to enhance the study of gene function and regulation in Staphylococcus aureus.

Authors:  Jeffrey L Bose; Paul D Fey; Kenneth W Bayles
Journal:  Appl Environ Microbiol       Date:  2013-01-25       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.